Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.00
Bid: 85.60
Ask: 87.10
Change: 0.00 (0.00%)
Spread: 1.50 (1.752%)
Open: 87.00
High: 87.00
Low: 87.00
Prev. Close: 87.00
CLI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Jul 2019 15:19

RNS Number : 4019E
CLS Holdings PLC
03 July 2019
 

 

CLS Holdings plc

 

(the "Company")

 

Notification of Transaction of Directors, Persons Discharging Managerial Responsibilities ("PDMR") or Persons Closely Associated

 

CLS Holdings plc Performance Incentive Plan ("PIP")

 

On 2 July 2019, the Remuneration Committee granted Mr Andrew Kirkman, Chief Financial Officer and Director of the Company, the following Awards over ordinary shares of 2.5 pence each in the capital of the Company under Element B of the PIP in the form of conditional share awards. These Awards form part of his recruitment remuneration in relation to the buying out on a fair value basis of his long-term incentive awards lapsing on leaving his previous employment:

 

Award

Number of Shares subject to the Award

Vesting Date

2017 Award

 

68,523

5 April 2020

2018 Award

 

56,305

5 April 2021

 

The key terms of the Awards made under Element B of the PIP are:-

- Awards will vest as above provided that the participant remains employed by the Company, and

- no shares subject to Awards (apart from those sold to meet any tax liability) can be sold prior to the 5th anniversary of the award date.

Full details of the PIP are set out in the Company's Remuneration Policy, together with details of Mr Kirkman's recruitment remuneration, are available at www.clsholdings.com

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

 

Notification of Dealing Form

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Andrew Kirkman

2

 

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of CLS Holdings Plc of 2.5 pence each.

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Grant of conditional share awards under the CLS Holdings plc Performance Incentive Plan.

c)

Price(s) and volume(s)

Price

 

 

Nil

 

Volume

 

 

68,523 (2017 Award)

 

56,305 (2018 Award)

d)

Currency

GBP - British Pound

e)

Aggregated information

 

N/A

f)

Date of the transaction

 

2 July 2019

g)

Place of the transaction

 

Outside a trading venue

 

 

 

 

Enquiries:

David Fuller

Company Secretary

CLS Holdings plc

LEI: 213800A357TKB2TD9U78

Tel: +44 (0) 20 7582 7766

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKNDDQBKDPOK
Date   Source Headline
15th Mar 20231:17 pmRNSDirector/PDMR Shareholding
10th Mar 20234:31 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSAnnual Financial Report
10th Feb 20235:02 pmRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSNotice of Full Year Results
17th Jan 20235:17 pmRNSDirector/PDMR Shareholding
20th Dec 20225:45 pmRNSDirector/PDMR Shareholding
29th Nov 202211:18 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSQ3 Trading Update
8th Nov 20227:00 amRNSCLS Secures Three New Leases in Germany
18th Oct 20223:14 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSDisposal
12th Oct 20223:28 pmRNSDirector/PDMR Shareholding
11th Oct 20224:33 pmRNSDirector/PDMR Shareholding
6th Oct 20225:48 pmRNSDirector/PDMR Shareholding
5th Oct 20225:13 pmRNSDirector/PDMR Shareholding
4th Oct 20221:12 pmRNSDirector/PDMR Shareholding
29th Sep 202211:26 amRNSDirector/PDMR Shareholding
23rd Sep 20223:06 pmRNSDirector/PDMR Shareholding
22nd Sep 20223:41 pmRNSDirector/PDMR Shareholding
16th Sep 20224:56 pmRNSCompletion of Tender Offer and Total Voting Rights
15th Sep 20223:57 pmRNSDirector/PDMR Shareholding
12th Sep 20224:14 pmRNSResult of Tender Offer
9th Sep 202212:23 pmRNSResult of AGM
15th Aug 20224:27 pmRNSTender Offer
10th Aug 20224:19 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSHalf-year Results
3rd Aug 20227:00 amRNSCLS announces the sale of three properties
2nd Aug 20225:38 pmRNSNotice of Results
14th Jul 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 202210:31 amRNSCLS reclassified as REIT on EPRA index
9th Jun 20222:09 pmRNSDirector/PDMR Shareholding
12th May 20222:05 pmRNSDirector/PDMR Shareholding
12th May 20222:01 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSDividend Policy Update
28th Apr 20223:24 pmRNSAGM Statement
14th Apr 202211:20 amRNSDirector/PDMR Shareholding
28th Mar 20224:19 pmRNSAnnual Financial Report
18th Mar 202212:54 pmRNSDirector/PDMR Shareholding
18th Mar 202212:52 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSAnnual Financial Report
9th Mar 20225:42 pmRNSDirector/PDMR Shareholding
8th Mar 20227:00 amRNSAcquisition
17th Feb 20227:00 amRNSAcquisition
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
10th Feb 20222:55 pmRNSHolding(s) in Company
9th Feb 20223:50 pmRNSDirector/PDMR Shareholding
9th Feb 202211:50 amRNSDirector/PDMR Shareholding
3rd Feb 202210:10 amRNSNotice of Results
26th Jan 202211:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.